Qinglong Jin

735 total citations
27 papers, 455 citations indexed

About

Qinglong Jin is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Qinglong Jin has authored 27 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 15 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Qinglong Jin's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (10 papers) and Hepatitis C virus research (8 papers). Qinglong Jin is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (10 papers) and Hepatitis C virus research (8 papers). Qinglong Jin collaborates with scholars based in China, United States and Canada. Qinglong Jin's co-authors include Lei Gao, Junqi Niu, Ruihong Wu, Xiuzhu Gao, Xiaomei Wang, Yanhang Gao, Yanfang Jiang, Jing Jiang, Hongqin Xu and Yu Pan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Journal of Hepatology.

In The Last Decade

Qinglong Jin

25 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qinglong Jin China 9 261 215 94 91 68 27 455
Luciana Costa Faria Brazil 12 361 1.4× 210 1.0× 38 0.4× 50 0.5× 80 1.2× 42 570
Gabriela Perdomo Coral Brazil 16 571 2.2× 446 2.1× 38 0.4× 66 0.7× 120 1.8× 55 756
Zunirah Ahmed United States 9 239 0.9× 190 0.9× 37 0.4× 15 0.2× 61 0.9× 25 385
Paola Magistroni Italy 11 146 0.6× 134 0.6× 30 0.3× 79 0.9× 96 1.4× 17 458
Laura Weichselbaum Belgium 7 139 0.5× 98 0.5× 68 0.7× 40 0.4× 42 0.6× 11 265
Vasilios Papastergiou Greece 18 315 1.2× 311 1.4× 56 0.6× 68 0.7× 527 7.8× 35 931
Stylianos Karatapanis Greece 15 261 1.0× 245 1.1× 43 0.5× 42 0.5× 311 4.6× 33 581
M. Shadab Siddiqui United States 10 251 1.0× 177 0.8× 58 0.6× 34 0.4× 102 1.5× 15 587
Agata Michalak Poland 12 128 0.5× 66 0.3× 38 0.4× 56 0.6× 51 0.8× 26 284
A. Merighi Italy 12 178 0.7× 148 0.7× 89 0.9× 29 0.3× 344 5.1× 38 676

Countries citing papers authored by Qinglong Jin

Since Specialization
Citations

This map shows the geographic impact of Qinglong Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinglong Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinglong Jin more than expected).

Fields of papers citing papers by Qinglong Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinglong Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinglong Jin. The network helps show where Qinglong Jin may publish in the future.

Co-authorship network of co-authors of Qinglong Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Qinglong Jin. A scholar is included among the top collaborators of Qinglong Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinglong Jin. Qinglong Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xin, et al.. (2024). Two sixth-order, L convergent, and stable compact difference schemes for the generalized Rosenau-KdV-RLW equation. Journal of Computational and Applied Mathematics. 459. 116382–116382.
2.
Wang, Yao, Yan Wang, Jianjie Huang, et al.. (2023). TR score: A noninvasive model to predict histological stages in patients with primary biliary cholangitis. Frontiers in Immunology. 14. 1152294–1152294. 2 indexed citations
3.
Chen, Qingling, et al.. (2023). The Albumin-Bilirubin Score as a Predictor of Liver-Related Mortality in Primary Biliary Cholangitis with Compensated Cirrhosis. Digestive Diseases. 41(6). 946–956. 2 indexed citations
5.
Wen, Xiaoyu, et al.. (2022). Analysis of clinical features and prognostic factors in patients with hepatic hydrothorax: a single-center study from China. BMC Gastroenterology. 22(1). 333–333. 5 indexed citations
6.
Wang, Xiaomei, Xiuzhu Gao, Ruihong Wu, et al.. (2022). Serum qAnti‐HBc combined with ALT and HBsAg predicts significant hepatic inflammation in HBeAg‐positive immune active patients. Journal of Gastroenterology and Hepatology. 37(9). 1806–1814. 8 indexed citations
8.
Wang, Xiaomei, Xiumei Chi, Ruihong Wu, et al.. (2021). Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment. Virology Journal. 18(1). 4–4. 22 indexed citations
9.
Chen, Qingling, et al.. (2021). The prognostic value of antibodies to gp210 among patients with primary biliary cholangitis in Northeast China. Digestive and Liver Disease. 54(8). 1094–1100. 7 indexed citations
10.
Wu, Ruihong, Xu Liu, Hongqin Xu, et al.. (2020). <p>Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients</p>. Journal of Hepatocellular Carcinoma. Volume 7. 219–232. 32 indexed citations
11.
Zhang, Hong, Cuiyun Li, Jingrui Liu, et al.. (2020). Safety and pharmacokinetics of a biosimilar of denosumab (KN012): Phase 1 and bioequivalence study in healthy Chinese subjects. Expert Opinion on Investigational Drugs. 30(2). 185–192. 6 indexed citations
12.
Zhang, Mingyuan, Ruihong Wu, Hongqin Xu, et al.. (2019). Changing incidence of reported viral hepatitis in China from 2004 to 2016: an observational study. BMJ Open. 9(8). e028248–e028248. 27 indexed citations
13.
Zhang, Mingyuan, et al.. (2019). Mutation in PHKA2 leading to childhood glycogen storage disease type IXa. Medicine. 98(46). e17775–e17775. 7 indexed citations
14.
Zhang, Mingyuan, et al.. (2019). Liver failure associated with benzbromarone: A case report and review of the literature. World Journal of Clinical Cases. 7(13). 1717–1725. 19 indexed citations
15.
Zhang, Yu, et al.. (2019). A case report of hereditary hemochromatosis caused by mutation of SLC40A1 gene. Medicine. 98(44). e17526–e17526. 1 indexed citations
16.
Li, Xu, Qinglong Jin, Hongqin Xu, et al.. (2017). Chronic hepatitis B patients with high liver fibrosis levels should receive antiviral treatment. Experimental and Therapeutic Medicine. 13(6). 3624–3630. 2 indexed citations
17.
Li, Xu, et al.. (2016). Association between ABO blood group and HCV-related hepatocellular carcinoma risk in China. Medicine. 95(49). e5587–e5587. 7 indexed citations
18.
Li, Wanyu, Yanfang Jiang, Qinglong Jin, et al.. (2011). Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population. Liver International. 31(8). 1118–1126. 66 indexed citations
19.
Jin, Qinglong, Yuki Moritoki, Ana Lleò, et al.. (2011). Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody–positive versus antimitochondrial autoantibody–negative primary biliary cirrhosis. Hepatology. 55(5). 1495–1506. 29 indexed citations
20.
Jin, Qinglong, et al.. (2011). Dyslipidemia in northeastern China. SHILAP Revista de lepidopterología. 6(2). 220–226. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026